.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Modern clinical practice relies heavily on portable and implantable electronic devices. Consequently, the demand for safe, high-performance energy storage is rising. Researchers recently unveiled a breakthrough in solid-state proton batteries using graphdiyne oxide (GDYO), which could redefine how we power medical technology.
This research addresses a major hurdle in battery science: low conductivity in solid electrolytes at room temperature. Specifically, the team constructed a three-dimensional hydrogen bonding network by combining GDYO with phosphoric acid. Furthermore, this GDYO@HPO4 electrolyte facilitates efficient proton transport through a sophisticated hopping mechanism.
Safety is paramount in medical applications, especially for internal devices like pacemakers. Notably, these batteries eliminate the need for flammable liquid electrolytes. Therefore, they offer a safer alternative for patients. Moreover, the assembled full solid-state battery demonstrated an ultrahigh charge-discharge rate of 50C, retaining over 50% capacity.
Longevity is another critical factor for implantable technology. Additionally, this system showed remarkable cycling stability, maintaining 90.2% capacity even after 4500 cycles. In contrast to current lithium-ion systems, these proton-based batteries could significantly extend the lifespan of life-saving medical devices.
Ultimately, the molecular-level design of GDYO provides a robust platform for advanced electrocatalysts. This research paves the way for high-performance, long-lasting energy solutions in healthcare.
Solid-state proton batteries use hydrogen ions as charge carriers and solid electrolytes. This design is generally safer and more stable than the liquid-based lithium-ion batteries found in many current portable devices.
A high charge rate allows medical devices to recharge rapidly. This feature is essential for emergency equipment and portable diagnostics that require immediate readiness in clinical settings.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always seek the advice of a physician or other qualified health provider regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Huang Y et al. Graphdiyne Oxide-Enabled Solid-State Proton Battery Exhibiting Superior Rate Capability. Angew Chem Int Ed Engl. 2026 Jun 20. doi: 10.1002/anie.4266547. PMID: 42322151.
2. ANSTO. A breakthrough in all-organic proton batteries for safer, sustainable energy storage. 2025.
3. Jiang W et al. Tumor Reoxygenation and Blood Perfusion Enhanced Photodynamic Therapy using Ultrathin Graphdiyne Oxide Nanosheets. Nano Lett. 2019.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A novel solid-state proton battery using graphdiyne oxide (GDYO) offers ultra-high charge rates and exceptional stability, paving the way for safer and more efficient medical devices.
4 months ago
Depemokimab offers twice-yearly dosing for severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, significantly cutting exacerbations and hospital admissions.
3 days back
A novel copper metal-organic framework hydrogel remodels the uterine microenvironment to stimulate robust endometrial regeneration, reduce intrauterine fibrosis, and restore reproductive fertility, offering a groundbreaking strategy for managing refractory endometrial damage and Asherman syndrome.
3 days back
New research reveals that non-ablative radiotherapy suppresses ventricular tachycardia by increasing conduction velocity via NaV1.5 upregulation and action potential prolongation. However, sustained sodium current elevation and depressed calcium handling highlight the need for careful clinical translation.
5 days back
A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
3 days back
A breakthrough study demonstrates that fullerol-primed extracellular vesicles generated in a 3D SECCS bioreactor attenuate ferroptosis and restore myogenic regeneration in diabetes via the FOXO3 pathway, offering a cell-free therapeutic strategy for diabetic musculoskeletal degeneration.
3 days back
